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Objective. Laparostomy can be applied in trauma, abdominal sepsis, intra-abdominal hypertension, or compartment syndrome.
Systemic infections, especially if complicated by Candida, are associated with a high risk of mortality. Methods. This is a single-
centre retrospective case series of 47 cases admitted to our Department, which required laparostomy procedure; we analyzed the
type of surgery, temporary abdominal closure, duration of open abdomen, complications, SOFA score, mortality with Candida
infections, and empirical or targeted antifungal therapy. Results. We found that patients with Candida infection were related
with a statistically signiﬁcant diﬀerence (p < 0 05) with a complication after OA closure, total complications, time elapsed after
OA application, time spent on the ﬁrst surgical OA application, type of temporary abdominal closure that is used, and duration
of the open abdomen. The use of empirical and targeted antifungal therapy is related to the duration of open abdomen too.
Conclusions. Management of the OA is often burdened by sepsis or septic shock, especially when complicated by Candida
infection. Candida score is a validated tool to identify patients who can be treated empirically, but every situation must be
considered on an individual basis.
1. Introduction
The open abdomen (OA) technique or laparostomy is a
surgical option nowadays considered acceptable for the
treatment of critically ill patients [1–3]. The key idea is to
leave the abdominal cavity open in order to reduce the
intra-abdominal pressure in case of abdominal hypertension
and/or to allow a better control of the abdominal cavity in
case of intra-abdominal infections. Abdominal contents are
exposed; thus, they need to be protected with a temporary
abdominal closure (TAC) [4]. Several TAC systems are used
nowadays [5–8]. Usually, the role of laparostomy is closely
linked to damage control surgery, especially in traumatized
patients [9]. It can also be adapted in advanced sepsis or in
the emergency treatment of acute peritonitis [4, 5, 10–14],
in order to prevent or control the frame of septic shock
[13, 15]. On this topic, the literature is still being debated
nowadays [3, 11]. Fascial closure can be realized <7 days
(early) or >7 days (delayed) after the initial OA procedure
[5]. The gold standard is the early fascial closure [5, 16–46],
in order to reduce complications, but in septic patients, it is
less likely to be achieved. Anyway, it should be performed
as soon as possible, when abdominal sepsis is under control
[5, 17–19]. It is widely reported in the literature that the
maintenance of OA predisposes patients to a further micro-
bial and fungal contamination [20]. Therefore, antibiotic
and antifungal therapies have an important role for control-
ling the source of sepsis and the risk of complications during
and after laparostomy. Most common complications in
OA, like bleeding, anastomosis leakage, EAF appearance, or
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multiorgan failure (MOF), are linked to sepsis, and they can
result in an increased mortality [5, 20, 21]. Several studies
have demonstrated the role of invasive Candida species
(spp.) infection in worsening sepsis or septic shock [22, 23].
Incidence of candidemia varies between 2 and 6.9 per 1000
admissions in ICU irrespective of the diagnosis of admission
[24, 25], and it is associated with a high mortality rate,
ranging from 35% to 60% [26]. The conditions of the
patients can be monitored with outcome prediction models,
just like the sequential organ failure assessment (SOFA)
[27], in order to correlate the number of dysfunctional
organs with the mortality in septic patients [28, 29]. The
study evaluates a continuative series of 47 cases treated in
the Emergency Surgery Department of Sant’Anna University
Hospital of Ferrara with a severe diagnosis of trauma, intesti-
nal ischemia, bleeding, or peritonitis which required OA. It
aims at considering the relation between Candida infections
and diagnosis, duration of the OA, type of TAC used, compli-
cations, and outcomes. It also associates this data with micro-
organism infection and the use of prophylactic or targeted
antifungal therapy.
2. Methods
In the Emergency Surgery Department of Sant’Anna
University Hospital of Ferrara, 44 patients were admitted
who required laparostomy (in the opinion of treating surgeon
and anaesthesiologist) between February 2010 and September
2016. Among them, 3 patients required a second laparostomy,
so a total number of 47 cases are taken into account. A written
informed consent was obtained from every patient or from
their legal delegates (at the time of intervention or during
follow-up). Inclusion criteria were age> 18 years and patients
with Björck 2016 Classiﬁcation System [30] grades 1a, 1b, 2a,
2b, and 2c. Exclusion criteria were age< 18 years, pregnancy,
malignancy, patients with Björck 2016 Classiﬁcation System
grades 3a, 3b, and 4. Data were collected by the computerized
hospital system and medical records. Source data included
preoperative parameters: age, sex, weight, height, admittance
diagnosis, and comorbidities. In our Department, diﬀerent
kinds of TAC were used [5]: Bogotà-Bag like (we used a like
sterile 3 litre saline bag cut, shaped, and sutured to fascial
edges) and Opsite Sandwich technique (we covered the abdo-
men with a sheet of polyethylene, surrounded by Opsite,
abdominal packs, two suction drains, and wall suction). This
two techniques could be associated with approaching skin as
in skin-only closure technique, realizing a mixed technique
and VAC therapy. Opsite Sandwich technique indication,
length of the OA (<7/>7 days) [46], and number and distance
of relooks were also considered. The study analyzed data in
relation to ileus, colon, or intra-abdominal parenchymal
organs (liver, pancreas, or kidney) involved. In the considered
cases, the stomach was never aﬀected. Complications have
been analyzed following the Clavien-Dindo classiﬁcation
[31]. In our study, we have considered bleeding which
required blood transfusion (grade IIa), intestinal ischemia
(grade IVb), anastomosis leakage (grade IIIb), post operatory
bilious ﬁstula (grade IIIa), entero-atmospheric ﬁstula (EAF)
(grade IIIa), wound dehiscence (grade IIa), and MOF (grade
IVb) among OA relooks and after OA deﬁnitive closure.
These parameters were correlated with bacterial and Candida
infections. Microorganisms were analyzed instead of detected
with bronchial, urine, blood, and peritoneal analyses in every
patient. Data were also related to time spent after OA applica-
tion and appearance of Candida infections (<7/>7 days) and
antimicrobial and antifungal therapies in both ICU and
Surgical Department with a follow-up of 2 months. Organ
dysfunction was evaluated using the SOFA score. Every case
was classiﬁed following 3 degrees of SOFA score steps in rela-
tion to mortality risk: <3, 3–9, and >9. For trauma, we used
the Injury Severity Score (ISS) classiﬁcation [32]. Data were
analyzed with statistic chi-square test, considering p < 0 05
as statistically signiﬁcant.
3. Results
The study included 47 cases of OA performed in 44 patients.
Three patients, all males, required a second laparostomy after
the closure of the previous one: two for peritonitis and one
for abdominal bleeding. Of 44 patients, 15 were females
(34%) and 29 were males (66%) with a female :male ratio of
1 : 1.9. The average age was 63 years (median 68, range
24–86), and the average ages of women and men were
69.7 and 58.8, respectively. Average BMI was 28.7 kg/m2
(range 17–47 kg/m2). Comorbidities and ASA score [33]
are shown in Table 1. We admitted 27/44 patients from
triage; 17/44 patients were already hospitalized in other
Hospital Departments (Table 2). All cases have been ana-
lyzed considering ileal, colonic, or other intra-abdominal
parenchymal organ involvement (Table 2). The 6 trauma-
tized patients were evaluated in triage using the ISS score:
the average value was 28.8 (range 21–38, median 27). The
study of statistical correlation showed the presence of a sig-
niﬁcant relation between the concerned intestinal tract and
the application of OA (p < 0 05). OA was applied to prevent
IAH in 21/47 cases (44.7%), while it was performed in the
presence of IAH in the other cases 26/47 (55.3%) [34]. The
Table 1: Comorbidities and ASA score.
Comorbidities N %
Hypertension 21 44.7
Heart diseases 16 34.0
Renal diseases 9 19
Pneumological disorders 3 6.4
Previous cancer 7 14.9
Immune suppression 1 2.1
Diabetes 7 14.9
Obesity 23 48.9
ASA score
I 2 4.3
II 7 14.9
III 19 40.4
IV 17 36.2
V 2 4.3
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SOFA score was <3 in 8/47 cases (17%), 3–9 in 15/47
(31.9%), and >3 in the other 24/47 cases (51.1%), so in 83%
of cases, there was a high risk of mortality related to sep-
sis. We also evaluated the duration of the OA maintaining
(<7 or >7 days) [5, 17] and the type of OA used [35]. In
32/47 cases (68.1%), OA was kept <7 days, while only in
15/47 (31.9%), OA was kept over 7 days. We used
Bogotà-Bag like in 27/47 cases (57.4%), Opsite Sandwich
technique in 6/47 cases (12.8%), and mixed technique
(Bogotà-Bag like or Opsite Sandwich technique+ skin-only
closure) in 12/47 cases (25.5%). VAC therapy was used only
twice (4.3%). Considering the 3 patients treated after a previ-
ous laparostomy, 2 of them kept OA< 7 days and only
one> 7 days. In all 3 cases and in both laparostomies, we
exploited Bogotà-Bag like TAC. Anastomosis was done in
34/47 cases (77.3%), 13/47 at the ﬁrst look (27.66%) and
21/47 at the following relooks (44.68%). In 13/47 cases
(27.66%), a temporary or deﬁnitive stoma was created. Only
3/47 cases (6.4%) developed EAF [36]. Almost always, but 4
cases (7.2%), abdominal wall was closed by direct closure.
In 4 cases, the closure was done by a biological prosthesis;
of them, 2 cases (1.8%) also needed a component separation
technique [37]. Complications appeared in 29/47 cases
(61.7%). Complications among relooks were 17/47 (36%):
abdominal hemorrhage in 8 cases (17%), development of
MOF in 6 cases (12.7%), anastomosis leakage in 2 cases
(4.2%), and caecum ischemia in 1 case (2.1%). Complications
after OA closure appeared in 21/47 cases (44.7%): hemor-
rhage in 2 cases (4.3%), anastomotic leakage in 4 cases
(8.5%), wound dehiscence in 6 cases (12.8%), MOF in 3 cases
(6.4%), and bilious ﬁstula in 2 cases (4.3%). Furthermore, in 4
cases, pulmonary thromboembolism was detected and
treated adequately (in Figure 1, complications are shown
among relooks and after abdominal closure). Several types
of bacteria were found in blood analysis in 19/47 cases
(40.4%) and in peritoneal analysis in 32/47 cases (68.1%).
Sometimes, diﬀerent kinds of microorganisms were found
in diﬀerent cultural analyses of the same case. The bacterial
population was very heterogeneous and therefore not suﬃ-
cient to allow for a statistically signiﬁcant analysis. Principal
bacteria species and their ﬁndings are shown in Table 3.
Candida spp. were detected in 17/47 cases (36.2%) and in
several cases, also in diﬀerent analyses of the same patient
(Table 4). Candida infection (revealed by blood and/or peri-
toneal cultures) appeared in 15/17 cases (88.2%). In the
remaining 2/17 cases (11.8%), C. parapsilosis and C. albicans
were evidenced in bronchial analysis only and they had not
been treated with an antifungal therapy. Bronchial Candida
contamination was not treated in agreement with the infec-
tious specialist because of a single colonization. Empirical
antifungal therapy was established at the moment of admis-
sion in ICU in 7/47 cases (14.9%), and only 4/47 (8.6%) of
them developed a subsequent Candida infection. In 3 of these
cases, C. albicans was detected in peritoneal ﬂuid analysis,
and in the latter case, C. glabrata and C. albicans were found
in peritoneal analysis and at the same time C. parapsilosys in
urine analysis. In 11/47 cases (23.4%), a targeted therapy was
applied only when cultures detected Candida spp. In our
study, there was no evidence of correlation between Candida
infection and the three diﬀerent grades of SOFA score,
near-operative death, the indication of OA application,
complications among relooks, diﬀerent intestinal involve-
ments, comorbidities (such as obesity, renal pathologies,
diabetes, and immune suppression), and the relation between
IAH and the creation of anastomosis or stoma (p > 0 05)
(Table 5). The overall mortality in our study is 13/44 patients
(29.5%): 4 women (9.1%) and 9 men (20.5%), 6 of them
(13.6%) with invasive Candida infection. Overall, 6 of the 17
patients aﬀected by Candida infections died (35.3%). In
one case, there was only bronchial Candida contamina-
tion; in 3 cases, targeted therapy was applied; and in 2
cases, patients were treated with empirical antifungal ther-
apy. We found a relation between Candida infection and
both complications after OA closure and total complications.
We also considered the elapsed time after the OA application
and the ﬁrst positive analysis for Candida spp. (<7 days or >7
days). We found a statistically signiﬁcant relation between
Table 2: Cases admitted, diagnosis, and abdominal involvement.
Diagnosis
Trauma/intestinal
bleeding
Ischaemia Peritonitis
Triage 6 (12.76%) 9 (19.14%) 12 (25.6%)
Already hospitalized 5 (10.6%) 7 (14.9%) 8 (17%)
Total 11 (23.4%) 16 (34%) 20 (42.6%)
Intestinal involvement
Ileus 4 (8.5%) 11 (23.4%) 3 (6.4%)
Colon 3 (6.4%) 5 (10.6%) 10 (21.3%)
Liver, spleen, kidney 3 (6.4%) 0 (0%) 5 (10.6%)
Reinterventions 1 (2.1%) 0 (0%) 2 (4.2%)
Pulmonary
thromboembolism
Complications
0 2 4 6 8 10
Bilious stula
Wound dehiscence
Intestinal ischemia
Aer abdominal closure
Among relooks
Anastomosis leakage
MOF
Abdominal
hemorrhage
Figure 1: Complicationsamongrelooksandafterabdominal closure:
in the picture are evidenced principal complications among and
after abdominal relooks.
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time spent on the ﬁrst surgical OA application and Candida
infection appearance. There was also a statistically signiﬁcant
relation between Candida infection and the duration of the
OA. We found a correlation between Candida and the type
of TAC used. This analysis also considered the two cases of
VAC therapy OA, even though they are not to be considered
statistically signiﬁcant. More infections occurred with the
use of Bogotà-Bag like; no infections occurred with Opsite
Sandwich technique and a provided equal in mixed
technique (Table 6, Figure 2). However, we did ﬁnd a statis-
tically signiﬁcant relation between antifungal therapy and
the total duration of the OA. In particular, antifungal ther-
apy was not used in the majority of OA which were kept
<7 days. Data showed that Candida infection is less fre-
quent when the duration of the OA is <7 days, as well
as the setting of empirical antifungal therapy. Conversely,
when OA is kept >7 days, antifungal therapy is used in
more cases (Table 6, Figure 2).
Table 3: Diﬀerent bacteria in blood and peritoneal analysis. We considered the total where we found the presence of bacteria, and we divided
them in base of blood or peritoneum detection.
Bacteria E. coli Klebsiella pneumoniae Enteorococcus faecalis/faecium Pseudomonas aeruginosa Staphylococcus/streptococcus
Total cases 22 (46.8%) 10 (21.3%) 21 (44.7%) 7 (14.9%) 29 (61.7%)
Peritoneum 19 (40.4%) 9 (19.1%) 16 (34%) 5 (10.6%) 21 (44.7%)
Blood 10 (21.3%) 2 (4.3%) 12 (25.5%) 5 (10.6%) 16 (34%)
Table 4: Diﬀerent Candida species and their ﬁndings.
Candida parapsilosis albicans glabrata mirabilis tropicalis
Bronchial 1 (5.9%) 4 (23.5%) 1 (5.9%) 0 0
Urine 1 (5.9%) 3 (17.6%) 1 (5.9%) 1 (5.9%) 1 (5.9%)
Peritoneum 0 10 (58.8%) 3 (17.6%) 0 0
Blood 0 2 (11.8%) 0 0 0
Table 5: Not statistically signiﬁcant (p > 0 05) and % among Candida infection, the three diﬀerent grades of SOFA score, near-operative
death, the indication of OA application, complications among relooks, diﬀerent intestinal involvements, and the relation between IAH and
the creation of anastomosis or stoma.
Candida infection
Yes No % at total cases (47) p > 0 05
Sofa score
<3 6 2 2.82 0.94
0.423–9 7 8 3.29 3.76
>9 14 10 6.58 4.7
Mortality rate
Dead 7 6 3.29 2.82
0.59
Alive 20 24 9.4 11.28
OA indication
Trauma bleeding 6 5 2.82 2.35
0.95Ischemia 9 7 4.23 3.29
Peritonits 12 8 5.64 3.76
Complications among relooks
With complications 10 7 4.7 3.29
0.88
Without complications 17 13 7.99 6.11
Intestinal involvement
Ileus 12 7 5.64 3.29
0.77Colon 10 8 4.7 3.76
Liver, spleen, kidney 5 5 2.35 2.35
IAH
Yes 14 12 6.58 5.64
0.57
No 13 8 6.11 3.76
Anastomosis
Yes 19 15 8.93 7.05
0.72
No 8 5 3.76 2.35
Stoma
Yes 8 3 3.76 1.41
0.24
No 19 7 8.93 3.29
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4. Discussion
Many aspects must be considered when OA is used, such as
the reason for application of the laparostomy, age, and
comorbidities of the patient, septic status, and hydration
conditions [5]. As revealed by Cristaudo et al. [36], currently,
there are no published reviews of prognostic factors with
regard to deﬁnitive fascial closure, mortality, and intra-
abdominal complications of patients being managed with
OA. Intra-abdominal infections are considered as emergen-
cies, and a successful outcome depends on early diagnosis,
an appropriate surgical treatment, and adequate antibiotic
therapy [47]. The control of invasive Candida infections is
related to a reduced mortality [23, 38, 47]; nevertheless,
criteria for starting an empirical antifungal therapy are poor.
In many cases, unnecessary starting of antifungal therapy can
cause resistance [39, 40]. The colonization rate of Candida
spp. reaches up to 80% in patients who reside in intensive care
units (ICUs) more than a week, and themean rate of develop-
ment of invasive disease is 10% in colonized patients [48].
Candida colonization is consideredmultifocal when the same
or two diﬀerent species are found in two or more nonadjacent
loci of the organism, such as urine or bronchial expectorate
[23]. As reported by Leroy et al. in [23], invasive Candida
infection was deﬁned by at least one positive blood culture
or peritonitis, diagnosed by macroscopic ﬁndings and direct
examination or positive culture for Candida in the peritoneal
ﬂuid collected during a surgical procedure. Invasive candide-
mia can be deﬁned using the criteria proposed by Leon et al. in
the “Candida score” [41]. Components of the Candida score
are severe sepsis, total parenteral nutrition, surgery, multifo-
cal Candida colonization, invasive mechanical ventilation,
central venous catheter, urinary catheter, antibiotic ther-
apy> 5 days in the last 2 weeks, renal replacement therapy,
insulin-dependent diabetes, and immune suppression [23].
In our study, the SOFA score was >3 in 39/47 cases (83%)
and total parenteral nutrition was always set at admission in
ICU, just like invasive mechanical ventilation, central venous
catheter, and urinary catheter. In cases where we found
multifocal colonization, we considered diabetes, immune
suppression, renal diseases, and previous antimicrobial ther-
apy without ﬁnding a statistically signiﬁcant relation with
Table 6: Statistical signiﬁcance at p < 0 05 and % among Candida infection and type of TAC used, duration of OA, total complications, and
complications after OA closure.
(a)
Candida
Yes No
Total cases (47) at
p < 0 05 and % p < 0 5
Total complications
Case positive 3 15 6.40 32
0.03
Case negative 14 15 29.60 32
Complications after OA closure
Case positive 11 10 23.40 21.28
0.03
Case negative 6 20 12.77 42.55
Duration of OA
<7 days 7 25 14.89 53.19
0.003>7 days 10 5 21.28 10.64
Type of TAC used
Bogotà-Bag like 9 18 19.15 38.30
0.04
Opsite Sandwich technique 0 6 0.00 12.77
Mixed 6 6 12.77 12.77
VAC 2 0 4.26 0.00
(b)
<7 days >7 days Total cases (47) at
p < 0 05 and % p < 0 5
Duration of OA
<7 days 3 3 6.38 6.38
0.01>7 days 4 7 8.51 14.89
No infection 25 5 53.19 10.64
(c)
OA length of stay
<7 days >7 days Total cases (47) at
p < 0 05 and % p < 0 05
Antifungal
Not used 22 4 46.81 8.51
0.02Empirical 4 6 8.51 12.77
Targeted 6 5 12.77 10.64
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Candida infection. Candida infection was not signiﬁcantly
related with immune suppression and insulin-dependent
diabetes. As reported by Leroy et al. [23], criteria for starting
empirical antifungal therapy in ICU patients are poorly
deﬁned and recent IDSA guidelines suggesting that “empirical
antifungal therapy should be considered in critically ill
patients with risk factors for invasive candidiasis and no other
known cause of fever” could lead to an overuse of antifungal
agents. Despite the literature is still being debated on this
topic, the “Candida score” can be considered an eﬀective tool
to guide clinicians in applying antifungal therapy. In our case
series, empirical therapy was set in 7 cases. In 2 cases,Candida
was found in bronchial expectorate without fever or multiple
colonization, so it was not treated, in agreement with the
infectious specialist. Targeted therapy was applied in 11 cases
after the detection of Candida spp. in peritoneum or in blood
analysis. The deﬁnitive decision to empirically treat Candida
is left at the single anaesthesiologist in our Department. Some
studies, as [20, 42], depict howmicrobial colonization evolves
during OA maintenance. Candida infection is not an excep-
tion, and the risk of the development increases with the
patient’s vulnerability [43]. In our case series, we underlined
that a longer OAmaintenance increases the risk of developing
Candida infection. In [47], it is reported that Candida perito-
nitis is burdened by a highmortality rate (about 38%) and our
case series attests to these values. Anyway, in our study, we
must consider some biases. First of all, the small number of
patients was considered, who developed Candida infection.
Furthermore, there were 2 patients which required VAC
therapy. However, in both cases, EAF appeared; therefore,
we decided to not use this device in further cases. Secondly,
our study is encumbered by the fact that during the admission,
in conditions of urgency, our Department works with
surgeons of diﬀerent teams; hence, the decision to create OA
and type of TAC is left at the discretion of the relevant sur-
geon. The great heterogeneity of bacteria detected in blood
and/or peritoneal analysis could be indicative for sample con-
tamination or colonization as conﬁrmed by the poor eﬃcacy
of antibiotic therapy to resolve the post operative infective
complications. Moreover, we showed the good response to
antifungal therapy. On the other hand, an important bias
has originated due to the possibility that the patient’s vulner-
ability could be linked to previous or actual antibiotic thera-
pies or concomitant infections. So we decided to evaluate
only Candida infection and OA management, with the aim
of understanding the presence or absence of a statistically
signiﬁcant relation. We are aware that our data need to be
integrated into a more complex analysis system. For this
reason, our Department has taken part in the IROAmulticen-
ter study [44, 45] and plans to realize a prospective study
considering OA management and Candida infection appear-
ance. The results of our case series showed that the use of
diﬀerent TACs, even Bogotà-Bag like, cannot be discouraged,
conﬁrming the results of the recent IROA multicenter study
[44]. The choice of exploiting OA not only in traumatized
patients, but also in peritonitis and sepsis, is a working treat-
ment in which we believe. Our idea is also enforced by an
unchanged death rate in a framework that is burdened by a
highmortality rate itself [44] in a high septic risk (SOFA score
in fact was >3 in 83% of cases). Surely, this is a case series
which concerns a small number of patients in a single centre,
but it can represent a starting point for a better and more
standardized way of treatment in diﬀerent situations regard-
ing serious diagnosis. Statistically signiﬁcant relations may
Candida infection
VAC
Mixed
Opsite Sandwich technique
Bogotà-Bag like
>7 days
<7 days
0 5 10 15 20 25 30
Length of OA
Type of TAC used
Without complications
Without complications
With complications
With complications
Total complications
Complications
aer OA closure
No Candida infection
Candida infection
Figure 2: Correlation among Candida infection and type of TAC used, duration of OA, total complications, and complications after
OA closure.
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be altered by the reduced number of cases, and our study can
be considered as an initial assessment of the relation between
Candida infection and the various aspects of laparostomy.
However, it remains an initial study. Our follow-up deliber-
ately analyzes short distance of time, to understand which
complications can occur during near-operative time.
5. Conclusions
OA technique and its use in critical situations are still hotly
debated in the literature. No matter how seemingly eﬀective,
the annexed life-treating complications, which require highly
experience in surgical, infectious, and anesthesiology treat-
ments, must be considered when using OA. The right choice
of TAC and the early fascial closure of the abdomen appear
to be essential to avoid additional risk situations. Candida
infection in debilitated patients, as well as patients who are
subjected to OA, implies a great risk to mortality. For this
reason, the treatment of invasive Candida infection should
be based on predictive models, such as the “Candida score”
without, in our opinion, forgetting to consider the needs and
the characteristics of every individual patient, in order to
avoid over- or underestimated treatment. Of course, much
remains to be done to achieve optimal results in the treatment
of this critical situation.
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